ArticleGenes & cancer2017

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review.

Christine Mehner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.